The global IV therapy and vein access devices market size was estimated at USD 28,910 million in 2024 and is predicted to hit around USD 48,000 million by 2034, growing at a CAGR of 5.2% from 2024 to 2034.
The IV therapy and vein access devices market deals with the provision of a critical medical procedure that involves the administration of fluids, medications, blood products, and nutrients directly into a patient's bloodstream through a vein. This method is essential for various medical treatments, especially when rapid or continuous delivery is required. The global market for IV therapy and vein access devices is experiencing robust growth driven by several factors, including the rising prevalence of chronic diseases and technological advancements.
With the growing demand for these services, there is an increasing strain on the healthcare workforce, leading to shortages of skilled professionals capable of performing these procedures. This shortage not only impacts patient care but also poses challenges for healthcare providers in meeting the growing demand for IV therapy and vein access services. Despite this, the rise in chronic diseases such as cancer, diabetes, and autoimmune disorders has further fueled the demand for IV therapy at home. This continued rise in home healthcare and advances in medical technology are expected to spur future growth in the IV therapy and vein access devices market.
Published by Ajit Bansod
